DRUG · Unmapped registry intervention
ZW171
Find medicine records ·
Find other trials using this name
Clinical trial
A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
NCT06523803
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedA Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Mesothelin-expressing Advanced Cancersunresolved
Interventions
ZW171DRUG
Sponsors & collaborators
Zymeworks BC Inc.lead sponsor
Mapped research locations
SeoulSouth Korea4New YorkNew York, United States1Los AngelesCalifornia, United States1NashvilleTennessee, United States1LondonUnited Kingdom1SeattleWashington, United States1PittsburghPennsylvania, United States1AuroraColorado, United States1LouisvilleKentucky, United States1ManchesterUnited Kingdom1DresdenGermany1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06523803 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.